Mufg Americas Holdings Corp Dexcom Inc Transaction History

Mufg Americas Holdings Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 01, 2022	BUY	$67.99 - $132.89 $67 - $132	1 Added 1.01%	100 $7,000
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $67 - $132	1 Added 1.01%	100 $7,000
Q4 2021 Dec 01, 2022	BUY	$129.87 - $162.82 $4,415 - $5,535	34 Added 52.31%	99 $53,000
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $4,415 - $5,535	34 Added 52.31%	99 $53,000
Q3 2021 Dec 01, 2022	BUY	$106.71 - $143.18 $6,936 - $9,306	65 New	65 $36,000
Q3 2021 Nov 05, 2021	BUY	$106.71 - $143.18 $6,936 - $9,306	65 New	65 $36,000

1,021

352M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.